Ask AI
Reduced Duration HMA in LR MDS
Randomized Phase II Trial of Reduced Treatment Durations With Hypomethylating Agents in Lower-Risk MDS

Released: December 17, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 17, 2025